Jose D. Herazo‐Maya

Author

Jose D. Herazo‐Maya

Also Known As

Herazo-Maya, Jose, Herazo-Maya, Jose D., J Herazo-Maya, J. Herazo-Maya, J.D. Herazo-Maya, Jose D Herazo-Maya, Jose D. Herazo-Maya, Jose D. Herazo‐Maya, Jose David Herazo-Maya, Jose Herazo-Maya

120

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Yale University University of Pittsburgh University of South Florida Imperial College London Alexander Fleming Biomedical Sciences Research Center

About

Jose D. Herazo‐Maya is an author at Yale University specializing in medicine, pulmonary fibrosis, and inflammatory lung disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.8K
2	Cell Biology	6	6	1.5K
3	Engineering	2	2	360
4	Public Health	2	2	200
5	Biostatistics	2	2	200

Jose D. Herazo‐Maya

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis Marta Bueno, Yen‐Chun Lai, Yair Romero, Journal of Clinical Investigation MitophagyInflammatory Lung DiseaseLung InflammationMitochondrial DysfunctionImmunology	2014	589
PD-1 up-regulation on CD4 <sup>+</sup> T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production Lindsay J. Celada, Jonathan A. Kropski, Jose D. Herazo‐Maya, Science Translational Medicine	2018	354
Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function Guoying Yu, Argyris Tzouvelekis, Rong Wang, Nature Medicine InflammationFibrosisMitochondrial FunctionLung InflammationPhysiology	2017	348
Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis Jose D. Herazo‐Maya, Imre Noth, Steven R. Duncan, Science Translational Medicine EngineeringInflammatory Lung DiseaseLung InflammationImmunologyPathology	2013	343
Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study Madeleine Scott, Katie Quinn, Qin Li, The Lancet Respiratory Medicine	2019	237
BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis Antje Prasse, Harald Binder, Jonas C. Schupp, American Journal of Respiratory and Critical Care Medicine	2018	204
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study Jose D. Herazo‐Maya, Jiehuan Sun, Philip L. Molyneaux, The Lancet Respiratory Medicine Inflammatory Lung DiseaseMedicineOutcome PredictionGenetic EpidemiologyIdiopathic Pulmonary Fibrosis	2017	183
Transcriptional regulatory model of fibrosis progression in the human lung John E. McDonough, Farida Ahangari, Qin Li, JCI Insight Inflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationPathologySystems Biology Model	2019	178
Extracellular Mitochondrial DNA Is Generated by Fibroblasts and Predicts Death in Idiopathic Pulmonary Fibrosis Changwan Ryu, Huanxing Sun, Mridu Gulati, American Journal of Respiratory and Critical Care Medicine	2017	170
Blockade of the Programmed Death-1 Pathway Restores Sarcoidosis CD4 <sup>+</sup> T-Cell Proliferative Capacity Nicole Braun, Lindsay J. Celada, Jose D. Herazo‐Maya, American Journal of Respiratory and Critical Care Medicine	2014	136

Page 1